|
Delayed
NYSE
01:30:02 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 386.11 USD | -0.46% |
|
-0.41% | +27.43% |
| 07/08 | RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating | MT |
| 05/08 | RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating | MT |
Group Bio-Rad Laboratories, Inc.: Relations chart
Private companies belonging to the same group as BIO-RAD LABORATORIES, INC.
| Company | Manager |
|---|---|
Bio-Rad Laboratories MEPE | - |
Bio-Rad Laboratories GmbH
 Bio-Rad Laboratories GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Michael Johann Mohl |
Select your edition
All financial news and data tailored to specific country editions
